The University of Chicago Header Logo

Connection

Ravi Salgia to Drug Interactions

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Drug Interactions.
Ravi Salgia
Connection Strength
0.166
Drug Interactions
  1. A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients. Expert Opin Drug Saf. 2015 Mar; 14(3):485-93.
    View in: PubMed
    Score: 0.124
  2. Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib. J Clin Pharmacol. 2019 12; 59(12):1632-1640.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.